Overuse of short-acting beta-agonist bronchodilators in COPD during periods of clinical stability
详细信息 查看全文
- 作者：Vincent S. Fana ; b ; vincent.fan@va.gov" class="auth_mail" title="E-mail the corresponding author ; Ina Gylys-Colwella ; Emily Lockea ; Kaharu Suminoc ; d ; Huong Q. Nguyene ; Rachel M. Thomasa ; Sheryl Magzamenf
- 关键词：Pulmonary disease ; chronic obstructive ; Metered dose inhaler ; Telemedicine ; Adrenergic beta-2 receptor agonists ; Adherence ; Medication
- 刊名：Respiratory Medicine
- 出版年：2016
- 出版时间：July 2016
- 年：2016
- 卷：116
- 期：Complete
- 页码：100-106
- 全文大小：703 K
文摘
- •
Overuse of short-acting beta-agonist inhalers was common in moderate to severe COPD.
- •
Worse disease severity and increased dyspnea were associated with overuse of SABA.
- •
Only half of overusers were on maximal maintenance inhaler therapy for COPD.
- •
Interventions to optimizing inhaled therapy should be considered to reduce overuse.